IPOs

Dermapharm targets $1bn IPO before end of quarter
GoinPharma
Fri, 01/12/18 - 10:38 am
Dermapharm
IPOs
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Endpoints
Tue, 01/9/18 - 04:40 pm
Evolus
Botox
Allergan
IPOs
DWP-450
biosimilars
A Biotech VC's Outlook For 2018
Forbes
Fri, 01/5/18 - 05:27 pm
biotech
venture capital
venture
M&A
IPOs
In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M
Endpoints
Tue, 01/2/18 - 07:41 pm
biotech
IPOs
PureTech
ARMO BioSciences
Menlo Therapeutics
Solid Biosciences
Biotech IPOs show no signs of slowing down in 2018
BioPharma Dive
Wed, 12/20/17 - 11:41 am
biotech
IPOs
Denali
Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials
Fierce Biotech
Fri, 12/8/17 - 10:50 am
Denali
IPOs
Alzheimer's disease
Parkinson's Disease
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases
Xconomy
Tue, 11/14/17 - 07:55 am
Denali Therapeutics
IPOs
Alzheimer's disease
The Biotech IPO Boom Will Continue, Nasdaq Execs Predict
Forbes
Fri, 11/10/17 - 09:44 am
biotech
IPOs
NASDAQ
Eli Lilly Considering IPO or Sale of Its Elanco Animal Health Business
TheStreet.com
Tue, 10/24/17 - 10:14 am
Eli Lilly
IPOs
Elanco
animal health
M&A
Eyeing an IPO, ADC Therapeutics fuels pivotal cancer trials with a $200M mega-round backed by AstraZeneca
Endpoints
Mon, 10/23/17 - 10:08 pm
ADC Therapeutics
IPOs
AstraZeneca
antibody-drug conjugate
Successful IPO for Rhythm Pharmaceuticals: +52%
GoinPharma
Sun, 10/15/17 - 12:34 pm
IPOs
Rhythm Pharmaceuticals
OrthoPediatrics prices $52m IPO
Mass Device
Fri, 10/13/17 - 09:40 am
OrthoPediatrics
IPOs
devices
Rhythm Pharma strikes a chord with oversubscribed $120M IPO
Fierce Biotech
Sat, 10/7/17 - 11:05 am
Rhythm Pharmaceuticals
IPOs
A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
Endpoints
Fri, 09/22/17 - 09:07 am
China
biotech
IPOs
NASDAQ
Zai Labs
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Endpoints
Wed, 09/6/17 - 10:37 am
Rhythm Pharmaceuticals
IPOs
obesity
rare disease
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin
Peregrine slashes R&D in a reorg that claims 60 jobs; Zai Labs in hunt for $150M IPO – report
Endpoints
Sat, 08/12/17 - 11:53 am
Peregrine Pharmaceuticals
reorganization
Zai Labs
IPOs
Eyeing an IPO, Sutro retools its $1B I/O deal with Celgene but stays focused on BCMA
Endpoints
Thu, 08/10/17 - 11:37 am
IPOs
Sutro
Celgene
BCMA
Kala Pharmaceuticals prices $90m IPO
Drug Delivery Business News
Thu, 07/20/17 - 06:00 pm
Kala Pharmaceuticals
IPOs
cataract surgery
Ionis-spinout Akcea prices IPO below expected range
Drug Delivery Business News
Sat, 07/15/17 - 11:23 am
Akcea
Ionis
IPOs
Volanesorsen

Pages